November 2020 FDA Recall Drug by Golden State Medical Supply Inc.
D-0112-2021 - FAILED DISSOLUTION SPECIFICATIONS

This Class II drug recall was voluntarily initiated by Golden State Medical Supply Inc. on November 17, 2020 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0112-2021

Reason for Recall
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Initiated
11-17-2020
Reported
12-09-2020
Quantity
11,922 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Golden State Medical Supply Inc.
Distributed Nationwide in the USA
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

Batch or Lot Expiration Information

Lot# : GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021